185 related articles for article (PubMed ID: 26947147)
21. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
22. [Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].
Fan JJ; Chai YH; Hu SY; He HL; Zhao WL; Wang Y; Li J; Lu J; Xiao PF; Sun YN; Wang W; Cao L
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):523-6. PubMed ID: 24267134
[TBL] [Abstract][Full Text] [Related]
23. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
Hui PY; Chen YH; Qin J; Jiang XH
Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
[TBL] [Abstract][Full Text] [Related]
24. Gene Expression and Resistance to Glucocorticoid-Induced Apoptosis in Acute Lymphoblastic Leukemia: A Brief Review and Update.
Lambrou GI; Adamaki M; Hatziagapiou K; Vlahopoulos S
Curr Drug Res Rev; 2020; 12(2):131-149. PubMed ID: 32077838
[TBL] [Abstract][Full Text] [Related]
25. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia.
Schmidt S; Rainer J; Riml S; Ploner C; Jesacher S; Achmüller C; Presul E; Skvortsov S; Crazzolara R; Fiegl M; Raivio T; Jänne OA; Geley S; Meister B; Kofler R
Blood; 2006 Mar; 107(5):2061-9. PubMed ID: 16293608
[TBL] [Abstract][Full Text] [Related]
26. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
[TBL] [Abstract][Full Text] [Related]
27. Thioimidazoline based compounds reverse glucocorticoid resistance in human acute lymphoblastic leukemia xenografts.
Toscan CE; Rahimi M; Bhadbhade M; Pickford R; McAlpine SR; Lock RB
Org Biomol Chem; 2015 Jun; 13(22):6299-312. PubMed ID: 25967739
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid resistance in childhood leukemia.
Kaspers GJ; Pieters R; Klumper E; De Waal FC; Veerman AJ
Leuk Lymphoma; 1994 Apr; 13(3-4):187-201. PubMed ID: 8049644
[TBL] [Abstract][Full Text] [Related]
29. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.
Bhadri VA; Trahair TN; Lock RB
J Paediatr Child Health; 2012 Aug; 48(8):634-40. PubMed ID: 22050419
[TBL] [Abstract][Full Text] [Related]
32. Bioenergetic modulation overcomes glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia.
Samuels AL; Heng JY; Beesley AH; Kees UR
Br J Haematol; 2014 Apr; 165(1):57-66. PubMed ID: 24456076
[TBL] [Abstract][Full Text] [Related]
33. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
[No Abstract] [Full Text] [Related]
34. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.
Lugthart S; Cheok MH; den Boer ML; Yang W; Holleman A; Cheng C; Pui CH; Relling MV; Janka-Schaub GE; Pieters R; Evans WE
Cancer Cell; 2005 Apr; 7(4):375-86. PubMed ID: 15837626
[TBL] [Abstract][Full Text] [Related]
35. Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Cario G; Fetz A; Bretscher C; Möricke A; Schrauder A; Stanulla M; Schrappe M
Ann Hematol; 2008 Sep; 87(9):709-16. PubMed ID: 18521602
[TBL] [Abstract][Full Text] [Related]
36. Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia.
Bwanika HC; Leo IR; Struyf N; Talanti A; Aswad L; Konnur A; Björklund AC; Heyman M; Rassidakis G; Erkers T; Seashore-Ludlow B; Jafari R; Pokrovskaja Tamm K
Sci Rep; 2024 Feb; 14(1):4000. PubMed ID: 38369625
[TBL] [Abstract][Full Text] [Related]
37. Role of Autophagy and Apoptosis in Acute Lymphoblastic Leukemia.
Huang FL; Yu SJ; Li CL
Cancer Control; 2021; 28():10732748211019138. PubMed ID: 34169775
[TBL] [Abstract][Full Text] [Related]
38. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
[TBL] [Abstract][Full Text] [Related]
39. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
40. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
